Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Notes Payables (2018 - 2024)

GeoVax Labs (GOVX) has disclosed Notes Payables for 5 consecutive years, with $142292.0 as the latest value for Q2 2024.

  • On a quarterly basis, Notes Payables changed N/A to $142292.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $142292.0, a N/A change, with the full-year FY2020 number at $183326.0, up 1366.61% from a year prior.
  • Notes Payables was $142292.0 for Q2 2024 at GeoVax Labs, down from $182844.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $183326.0 in Q4 2020 to a low of $12048.0 in Q1 2020.
  • A 3-year average of $147578.8 and a median of $182481.5 in 2020 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: fell 3.62% in 2020, then skyrocketed 1417.63% in 2021.
  • GeoVax Labs' Notes Payables stood at $183326.0 in 2020, then decreased by 0.26% to $182844.0 in 2021, then decreased by 22.18% to $142292.0 in 2024.
  • Per Business Quant, the three most recent readings for GOVX's Notes Payables are $142292.0 (Q2 2024), $182844.0 (Q1 2021), and $183326.0 (Q4 2020).